Conference Highlights

The morning began with a breakfast N.E.X.T. Day session sponsored by Bristol-Myers Squibb. Peg Esper, DNP, ANP-BC, AOCN, discussed Opdivo (nivolumab) therapy, which is a fully human monoclonal antibody indicated for previously treated metastatic non–small-cell lung cancer. She reviewed the CheckMate 057 study, which looked at standard-of-care therapy, docetaxel, and Opdivo.

More than 900 nurse and patient navigators converged on the Las Vegas Aria today to kick off AONN+’s Seventh Annual Navigation & Survivorship Conference! For participants, the day began with the long-awaited nurse navigation and patient navigation certification exams. These are the industry’s first certifications specifically for navigators, and AONN+ is honored to be setting the standard in this area.

After a great night out on the town, guests of AONN+’s East Coast Regional Meeting got right to work on Sunday morning. Meeting Chair Sharon Gentry, RN, MSN, CBCN, CBEC, greeted the audience with a recap of the prior day. She then provided an overview of the activities for the last day.

Guests of AONN’s East Coast Regional Meeting were back to business bright and early Saturday. For patient navigators, this meant spending their morning sitting the Oncology Patient Navigator-Certified Generalist beta exam.

Over the past 24 hours, more than 200 nurse and patient navigators have converged on the Hyatt Regency in New Orleans, Louisiana, for the inaugural AONN East Coast Regional Meeting. Activities kicked off early in the afternoon with an Oncology Patient Navigator Code of Ethics workshop, presented by Mandi Pratt-Chapman, MA, and Linda Fleisher, PhD, MPH, for nonclinical navigators.